Indegene Limited — Updates, 11-02-2025: Press Release

Everest Group has recognized Indegene as a front-runner in the generative AI (GenAI) life sciences market. In their report, "AI-deas to Action: Operationalizing Generative AI in Life Sciences," they highlighted Indegene's comprehensive capabilities, including scale, diverse use cases, strategic partnerships, and the significant value delivered to clients. Indegene is noted for its holistic GenAI strategy and production-ready solutions that enhance productivity in clinical, medical, and commercial aspects of the life sciences value chain. The assessment focused on key parameters such as revenue, client reach, quality of industry-specific use cases, and the measurable value achieved by clients. This recognition underscores Indegene's commitment to facilitating transformative business impacts for life sciences leaders by leveraging GenAI effectively. The company serves a wide range of clients, including the top 20 biopharma firms and emerging biotech companies, indicating a strong market position with potential for continued growth.